Scapuloperoneal Myopathy and Cardiomyopathy with a Novel MYH7 Mutation: A Case Report by Hooshmand, Sara & Govindarajan, Raghav
Clinic Stuff
20This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
RRNMF Neuromuscular Journal 2020;1(2):20-21
Scapuloperoneal Myopathy and 
Cardiomyopathy with a Novel MYH7 
Mutation: A Case Report
Sara Jasmin Hooshmand, BS1 and
Raghav Govindarajan, MD1,2
1School of Medicine, University of Missouri, 
Columbia, MO, USA
2Department of Neurology, University of Missouri, 
Columbia, MO, USA
Introduction
Myosin heavy chain 7 (MYH7) gene encodes for myo-
sin heavy chain-beta (MHC-β), which is the major protein 
comprising thick filaments in cardiac muscle and in slow 
twitch type 1 fibers of skeletal muscles.1 
MYH7-related myopathies have variable clinical fea-
tures, onsets, and are emerging as a group of muscle dis-
eases that affect a wide range of age groups.11 MYH7 gene 
mutation-related myopathy has been reported in hyper-
trophic cardiomyopathy (HCM, MIM # 196200), dilated 
cardiomyopathy (DCM, MIM # 115200), Laing distal my-
opathy (MPD1; MIM # 160500), myosin storage myopathy 
(MSM, MIM # 608358), and congenital fiber type dispro-
portion (CFTD, MIM # 255310).2-4 Additionally, scapulo-
peroneal, limb girdle muscle form, multi-mini-core disease 
with variable cardiac involvement has been reported with 
MYH7 gene mutations. 13-14
While individuals with MYH7-related myopathies will 
present with cardiac or skeletal involvement, it is less com-
mon to see cardiac and skeletal involvement co-occurring 
in a single individual.2,11 In this case report, we describe a 
patient with ascending muscular weakness and dilated car-
diomyopathy with a heterozygous MYH7 gene mutation. 
Case Report
A 66-year old right-handed woman presented to the 
outpatient Neurology Clinic for evaluation of progressive 
ascending weakness and dyspnea. The patient first noted 
lower extremity weakness in her 20s that has slowly pro-
gressed to her upper extremities in her 50s. The patient re-
ported an extensive family history of progressive muscular 
weakness and cardiomyopathy. The patient reported her fa-
ther passed away from a myocardial infarction 43 years old, 
and son died from heart failure at 33 years old. Per patient, 
no further details were known about the cause of death. Pa-
tient reported no formal genetic testing has been done for 
any family members and was not interested in genetic test-
ing despite it being offered at our clinic. 
Upon presentation to the Neurology clinic, patient stat-
ed she is no longer able to raise her arms above her head, 
bend to put her shoes on, and has difficulty using her hands. 
Patient also reported new onset of exertional dyspnea. 
Neurological examination of mental status and cranial 
nerves were intact. On a manual muscle test, patient was 
unable to raise her arms above her head. Her strength on 
Medical Research Counsil (MRC) 0/5 strength of deltoids 
bilaterally, 4/5 strength of triceps and biceps bilaterally, 
and 3/5 strength at wrist extensors bilaterally. The patient 
had wasting of the thenar eminences and weak hand grip 
bilaterally. Furthermore, the patient had a 3/5 strength of 
hip flexion bilaterally, 3/5 strength of knee flexors and ex-
tensors bilaterally, and 1/5 strength of ankle dorsiflexion 
bilaterally. Reflexes were 1+ bilaterally throughout exam, 
and the patient had a wide-based, waddling gait. Lastly, high 
arched feet with hammertoes were noted.
There was no elevation of serum creatinine kinase, 
and EMG showed myopathic process. Muscle biopsy of the 
deltoid reported from outside facility revealed myopathic 
changes with mini cores. Unfortunately, no biopsy images 
were available from outside institution. The cardiac evalua-
tion included EKG and Echocardiogram. EKG reveals first 
degree AV block with anterior ischemia. Patient’s echo-
cardiogram revealed features of dilated cardiomyopathy, 
including left ventricular dilation with reduced systolic 
function and normal wall thickness. The genetic panel was 
conducted through PerkinElmer Genomics and revealed 
c.4522_c.4524del (p.Glu1508del) resulting in pathogenic 
mutation of MYH7, with a scapuloperoneal myopathy and 
cardiomyopathy phenotype.
Discussion
MYH7, which encodes for myosin heavy chain-beta, 
plays a crucial role in cardiac contractility and skeletal mus-
cle fibers. Previous studies have reported mutations in the 
NH globular head, and COOH tail of MYH7 gene resulted 
in cardiomyopathy and skeletal myopathies, respectively.5,8 
However, research has shown that the location of the mu-
tation and phenotypes do not necessarily correspond. 6-10 
Our case report reveals the location of the MYH7 gene 
mutation is in the COOH tail domain (c.4522_c.4524del: 
p.Glu1508del) , which resulted in co-occurring scapulopero-
neal and dilated cardiomyopathy in an adult patient. Similar 
to our case report, there has been reported cases of skeletal 
muscle myopathy with associated cardiomyopathy.5,7-8,10,15-17
Specifically, a study by Yüceyar et al has many parallels 
to the case report we present. 7 One member from the study 
family reported by Yüceyar had a unique presentation of a 
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slowly progressive scapuloperoneal type weakness with a 
normal creatine kinase level. In this individual, Yüceyar re-
ported exertional dyspnea with echocardiogram findings of 
dilated cardiomyopathy.7 These unique combination find-
ings were almost identical to the patient described in our 
case report. However, in contrast to our report, Yüceyar 
identified a homozygous mutation in MYH7 exon. Of the 
cases reported with co-occurring skeletal myopathy and 
cardiomyopathy findings, only two to date were noted to be 
homozygous.7-8
Our case, like the majority of MYH7 mutations with 
co-occurring skeletal and cardiac myopathies, demonstrat-
ed a heterozygous mutation.5,10,15-17 Furthermore, while our 
patient’s family was not interested in receiving genetic test-
ing, the history of multiple family members affected in each 
generation is highly suggestive of an autosomal dominant 
pattern of transmission. 
In conclusion, this case report highlights the pertinent 
family history that is commonly associated with MYH7 mu-
tations. It also illustrates the variability in the phenotypic 
presentation of this novel mutation. 9-11 While it is still not 
well understood why different MYH7 mutations result in 
various phenotypes, we hope that this unique combination 
of clinical findings will help increase awareness to the broad 
phenotypic spectrum related to MYH7-myopathies.
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